| Century Therapeutics

Biotechnology · Cell & Gene Therapy
Sponsors visas
2Open roles
$210kMedian advertised pay$150k – $150k
Lately:6 news stories in 90 daysFollow changes →

Facts

as of Nov 17, 2026

Century Therapeutics is on a mission to develop innovative allogeneic, iPSC-derived NK and T cell therapies that are more effective, tolerable, accessible, and affordable versus existing cells therapies.

It is hiring: 2 open roles, 0 of them posted in the last 30 days.

Open roles
2 in 3 citiesAlion job postings
Website
centurytx.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Hiring slowly: few roles were posted lately.

Leadership is the largest family, 33 of open roles.

0%Remote roles0 of 2
3Hiring offices
Can they hire you from United States?by your location
Likely
3 open roles are in your country: you apply locally, no move needed.
United States3On site
Remote, from elsewhere0Rare
No posting offers visa sponsorship. Remote roles: 0.
Alion signals0-100
Demand4
Pay21
Your chance35
How badly they need people, whether they pay, how realistic getting in is.
Where the openings areshare of open roles · trend
Leadership33▼
Industrial Engineering33▲
Biotech33▲
Newest roles
Senior Director, Clinical Operations
$240k – $270k per year · In office · Full-Time · 12+ years exp · United States
Engineer, Process Development
$130k – $150k per year · In office · Full-Time · 10+ years exp · PhD · United States
Degree asked
Doctoral Degree (PhD) 100%
1 postings state a degree.
Benefits named in postingsshare of open roles
Vision insurance2100%
401k plan2100%
Contract type
Full-Time 2
Visa sponsorship: none statedRelocation: none stated
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family

Pay

What its postings pay, by level.

$210kMedian
$150k – $150kTypical rangeUSD a year
$270kHighest paying roleSenior Director, Clinical Operations
Source: the pay stated in the company's postings, normalised to USD a year

Named in the work visa registers of United States.

0H-1B filings in 12 months
0Open roles in United States

In the register as Century Therapeutics, Inc., Philadelphia, PA

Other sponsors in the same field
Alert me
US Department of Labor · latest filing Apr 24, 2025

Footprint

Hiring in 3 cities in 1 country.

3Cities
1Countries
Loading the map
SiteTypeOpen rolesHires most forEngineering
Branchburg United StatesRegional office0
Philadelphia United StatesRegional office0
Boston United StatesRegional office0
Source: office addresses in postings and company registers

Tech stack

Technologies named in job postings at | Century Therapeutics over the last 12 months, by layer, with the share of postings for each.

7Technologies in use
2Postings analysed
52/100Stack modernity
Sign in to see how your skills match this stackSign In
Source: the technologies named in the company's postings and on its site

Newsroom

Sep 242026
News · Century Therapeutics stock falls 6.88 percent as milestones approach
Century Therapeutics stock traded at USD 1.76 on September 23, 2026, 42.1 percent below its 52-week high. Q2 EPS was USD -0.17 versus USD -0.11 consensus.
Sep 202026
News · Century Therapeutics stock extends strong run as IPSC jumps over 700 percent in 12 months
Century Therapeutics stock has gained about 701.1 percent in market capitalization over the past 12 months as of September 18, 2026. The IPSC share price recently stood near USD…
Sep 102026
Press release · The Globe and Mail
Detailed price information for Century Therapeutics Inc (IPSC-Q) from The Globe and Mail including charting and trades.
Sep 102026
News · markets.businessinsider.com
PHILADELPHIA, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. ('Century', NASDAQ: IPSC), a biotechnology company developing induce...
Sources: the outlets named on each headline, each story once